Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Persistent babesiosis in a stem cell transplant recipient.

Lubin AS, Snydman DR, Miller KB.

Leuk Res. 2011 Jun;35(6):e77-8. doi: 10.1016/j.leukres.2010.11.029. Epub 2010 Dec 24. No abstract available.

2.

Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.

Wormser GP, Prasad A, Neuhaus E, Joshi S, Nowakowski J, Nelson J, Mittleman A, Aguero-Rosenfeld M, Topal J, Krause PJ.

Clin Infect Dis. 2010 Feb 1;50(3):381-6. doi: 10.1086/649859.

3.

Atovaquone in the treatment of Babesia microti infections in hamsters.

Wittner M, Lederman J, Tanowitz HB, Rosenbaum GS, Weiss LM.

Am J Trop Med Hyg. 1996 Aug;55(2):219-22.

PMID:
8780464
4.

Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.

Jefferies R, Ryan UM, Jardine J, Robertson ID, Irwin PJ.

Exp Parasitol. 2007 Oct;117(2):115-23. Epub 2007 Apr 3.

PMID:
17543304
5.

Response of babesiosis to a combined regimen of quinine and azithromycin.

Shaio MF, Yang KD.

Trans R Soc Trop Med Hyg. 1997 Mar-Apr;91(2):214-5. No abstract available.

PMID:
9196774
6.

Atovaquone and azithromycin for the treatment of babesiosis.

Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR 3rd, Brassard P, Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A.

N Engl J Med. 2000 Nov 16;343(20):1454-8.

7.

First molecular identification of Babesia gibsoni in dogs from Slovakia, central Europe.

Víchová B, Horská M, Blaňarová L, Švihran M, Andersson M, Peťko B.

Ticks Tick Borne Dis. 2016 Feb;7(1):54-9. doi: 10.1016/j.ttbdis.2015.08.004. Epub 2015 Aug 10.

PMID:
26304014
8.

Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin.

Sakuma M, Setoguchi A, Endo Y.

J Vet Intern Med. 2009 May-Jun;23(3):493-8. doi: 10.1111/j.1939-1676.2009.0300.x.

9.

Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report.

Vyas JM, Telford SR, Robbins GK.

Clin Infect Dis. 2007 Dec 15;45(12):1588-90. doi: 10.1086/523731.

10.

Transfusion-transmitted babesiosis in an immunocompromised patient: a case report and review.

Wudhikarn K, Perry EH, Kemperman M, Jensen KA, Kline SE.

Am J Med. 2011 Sep;124(9):800-5. doi: 10.1016/j.amjmed.2011.03.009. Epub 2011 Jun 16. Review.

PMID:
21683324
11.

Quinine in the treatment of Babesia divergens infections in humans.

Brasseur P, Lecoublet S, Kapel N, Favennec L, Ballet JJ.

Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):840-1. No abstract available.

PMID:
8950568
12.

Complications of coinfection with Babesia and Lyme disease after splenectomy.

Abrams Y.

J Am Board Fam Med. 2008 Jan-Feb;21(1):75-7. doi: 10.3122/jabfm.2008.01.060182. No abstract available.

13.

Babesiosis in humans: a treatment review.

Weiss LM.

Expert Opin Pharmacother. 2002 Aug;3(8):1109-15. Review.

PMID:
12150690
14.

Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin.

Di Cicco MF, Downey ME, Beeler E, Marr H, Cyrog P, Kidd L, Diniz PP, Cohn LA, Birkenheuer AJ.

Vet Parasitol. 2012 Jun 8;187(1-2):23-7. doi: 10.1016/j.vetpar.2012.01.006. Epub 2012 Jan 8.

PMID:
22305297
15.

[Babesiosis in an immunocompromised German patient].

Häselbarth K, Kurz M, Hunfeld KP, Krieger G.

Med Klin (Munich). 2008 Feb 15;103(2):104-7. doi: 10.1007/s00063-008-1014-2. German.

PMID:
18270666
16.
17.

The treatment of babesiosis.

Ranque S.

N Engl J Med. 2001 Mar 8;344(10):773-4. No abstract available.

PMID:
11236790
18.

Atovaquone and azithromycin treatment for babesiosis in an infant.

Raju M, Salazar JC, Leopold H, Krause PJ.

Pediatr Infect Dis J. 2007 Feb;26(2):181-3.

PMID:
17259886
19.

Efficacy of azithromycin for treating Babesia microti infection in the hamster model.

Weiss LM, Wittner M, Wasserman S, Oz HS, Retsema J, Tanowitz HB.

J Infect Dis. 1993 Nov;168(5):1289-92.

PMID:
8228366
20.

Fever of unknown origin (FUO) due to babesiosis in a immunocompetent host.

Cunha BA, Cohen YZ, McDermott B.

Heart Lung. 2008 Nov-Dec;37(6):481-4. doi: 10.1016/j.hrtlng.2008.01.003. Epub 2008 Sep 30.

PMID:
18992633
Items per page

Supplemental Content

Write to the Help Desk